A pilot evaluation of the tolerability,
β
Robert A. Hauser; Eric Molho; Heidi Shale; Simon Pedder; Ernest E. Dorflinger
π
Article
π
1998
π
John Wiley and Sons
π
English
β 489 KB
## Abstract Tolcapone is a potent, reversible catecholβOβmethyltransferase (COMT) inhibitor with both peripheral and central activity. It has been demonstrated to improve motor function and allow levodopa dose reductions in Parkinson's disease (PD) patients who are experiencing either a stable resp